Skip to main content

Blood Collection Devices Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Analysis

Key Companies in Blood Collection Devices Market are Becton, Dickinson, and Company (BD), Medtronic, Terumo Medical Corporation, Haemonetics Corporation, Fresenius SE & Co. KGaA, Nipro Medical Corporation, FL MEDICAL s.r.l., GmbHer Bio-One International GmbH.

Pune, India, Oct. 11, 2021 (GLOBE NEWSWIRE) — The global “blood collection devices market” size is projected to experience dynamic growth in the forthcoming years owing to the rising awareness regarding blood tests across the world, finds Fortune Business Insights™ in its report, titled “Blood Collection Devices Market, 2021-2028”.

In recent years, the blood collection has gained prominence in order to effectively manage and diagnose a variety of diseases. There has been an increasing awareness about blood tests among the world population due to the rising number of fatal diseases such as cancer, heart attack, and others across the world. Thus, this is a crucial factor responsible for the growth of this market. For instance, as per the report released by the National Cancer Institute, in 2018, there were approximately 1,735,350 new cases of cancer that were diagnosed in the US.

However, the lack of adequate blood tests in the developing countries is projected to hamper the growth of this market.


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/blood-collection-devices-market-103500


List of Key Players Covered in the Blood Collection Devices Market Report:

  • Becton
  • Dickinson, and Company (BD),
  • Medtronic, Terumo Medical Corporation
  • Haemonetics Corporation
  • Fresenius SE & Co. KGaA
  • Nipro Medical Corporation
  • FL MEDICAL s.r.l.
  • GmbHer Bio-One International GmbH

In spite of the outbreak of the COVID-19 pandemic worldwide, there is a growing need for blood collection and blood tests across several regions in the market. Thus, this pandemic has not affected the growth of the blood collection devices market, which acts as a driving factor for this market’s growth.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/blood-collection-devices-market-103500


Market Segmentation:

On the basis of product, this market is classified into blood collection tubes – plasma separation tube, heparin tubes, serum separation tubes, EDTA tube, rapid serum tubes, coagulation tubes, needles and syringes, and others. By method, the market is divided into manual blood collection and automated blood collection. Based on end-user, the market is categorized into hospitals and clinics, diagnostic and pathology centers, blood banks, and others. In terms of geography, the market is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Highlights/Summary:

The report provides an exhaustive assessment of each market segment and also offers an in-depth analysis of the market drivers, trends, opportunities, and hindrances. Furthermore, the report contains a granular examination of the regional developments impacting the market, along with a thorough evaluation of the top market players and their key strategies.


Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/queries/blood-collection-devices-market-103500


Drivers/Restraints:

Increasing Investments in the Healthcare Sector to Fuel the Market

Nowadays, the governments of several countries are making efforts to increase the investments in the healthcare industry due to the rapid development of healthcare facilities across the world. Thus, this is an important factor responsible for the growth of this market across several regions.

Regional Insights:

Rising Prevalence of Chronic Diseases to Boost the North America Market Growth

North America region is projected to dominate the blood collection devices market share on account of the rising prevalence of chronic diseases in the countries such as the US and Canada.

Europe is anticipated to grow at a decent pace in this market due to the advanced healthcare infrastructure in the countries such as the UK, France, Germany, and others.

Competitive Landscape:

Strategic Alliances between Key Players to Feed Competition

The prominent companies in the blood collection devices market are focusing on the strategic collaborations with the small-scale and large-scale companies in order to increase the blood collection and testing across numerous regions in the market. This has resulted in the increasing competition among key companies which will help them to widen their business horizons and expand their market position.


Quick Buy Blood Collection Devices Market: https://www.fortunebusinessinsights.com/checkout-page/103500


Industry Development:

July 2020: Magnolia Medical launches Steripath Gen2 with integrated syringe, addressed to the patients with difficult intravenous access (DIVA) or the ‘hard stick’ patient population.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.